Oxford Nanopore Technologies Ltd., a privately held company that is developing a disruptive technology platform for the electronic, label-free analysis of single molecules, today announced that it has raised GBP17.4 million ($28 million) in new funding.

Samsung Electronics today announced that the industry's first 30-nanometer-class DRAM has just successfully completed customer evaluations, in two gigabit densities.

The Agency for Science, Technology and Research (A*STAR) announced today the successful induction of four new members namely Bombardier, Bodycote, Roesler and a local SME, Addvalue Technologies, into its Aerospace Programme. Including the new members, there are now 18 companies in the consortium, of which seven are local companies

Multifunctional nanoparticles are at the core of a growing field called theranostics that develops technologies physicians can use to diagnose and treat diseases in a single procedure. The major promise of theranostics is to bring together key stages of a medical treatment, such as the diagnosis and therapy, and thus to make a treatment shorter, safer and more efficient. Theranostic approaches require adequate tools with a high multi-functionality and selectivity. The initial phase of the development of theranostics has already revealed the two general challenges: lack of multifunctional methods and agents, and the lack of selectivity and specificity of available agents - that ultimately requires cell and molecular levels. Researchers have now developed a novel method based on gold nanoparticle-generated transient photothermal vapor nanobubbles, a structure they refer to as plasmonic nanobubbles.

A new testing method is being developed to detect cancer soon after the tumor has formed. It will identify characteristic substances in the blood which accompany a certain type of tumor. The first steps in the development have already been completed.

The Flexible Display Center (FDC) at Arizona State University today announced that the Printable Electronics Technology Center (PETEC) has become an Associate Member to collaborate on high-performing organic thin film transistors (OTFTs) for flexible display applications.

NanoInk, Inc. has pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery Division.

Scientists at Georgia Tech and the Ovarian Cancer Institute have further developed a potential new treatment against cancer that uses magnetic nanoparticles to attach to cancer cells, removing them from the body.

New analysis from Frost and Sullivan, Rapid Advances in HIV/AIDS Clinical Diagnostics, finds that technological advancements address outstanding and new issues associated with diagnosis and monitoring of HIV infections by providing simplified, cost-effective, and precise testing.

The 3rd European Conference for Clinical Nanomedicine is calling for papers on original research aimed at future or current clinical application of nanoscience.

Solar Thin Films, Inc. today announced that it intends to acquire Algatec Equity Partners LP, which owns a 47% equity interest in the capital stock of Algatec Solar AG, a growing producer of silicon crystalline solar panels and modules.

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, biotechnology research and development tools and medical diagnostics businesses, today outlined key milestones for 2010, which are expected to have a significant impact on the solar, biotechnology and medical diagnostics industries.

Analytical and Bioanalytical Chemistry Best Paper Award 2009 goes to Jean-Philippe Frimat for research on plasma stencilling methods for cell patterning.

'Nanotechnology: balancing the promises' is an electronic publication about the evolution of nanotechnology.

'Optical methods for particle size and zeta potential determinations with an overview of acoustical techniques' will be the subject of a presentation in March 2010 by Fraser McNeil-Watson, manager of the Novel Measurement Group at Malvern Instruments at a meeting on the 'Characterisation of sub-micron and nano-sized particles'.

Starpharma Holdings Limited today announced the signing of a new agreement with Eli Lilly and Company under which Starpharma's dendrimer drug delivery technology will be applied to enhance compounds in Lilly's human pharmaceutical portfolio.

The International SEMATECH Manufacturing Initiative (ISMI) today announced that Applied Materials, Inc. has become the newest member of the award-winning Environment, Safety and Health (ESH) Technology Center. Applied will join leading semiconductor manufacturers in cooperative projects for sustainable manufacturing, industry environmental standards and green practices in chip-making.

Northwestern University researchers are the first to design a bioactive nanomaterial that promotes the growth of new cartilage in vivo and without the use of expensive growth factors. Minimally invasive, the therapy activates the bone marrow stem cells and produces natural cartilage. No conventional therapy can do this.

PI (Physik Instrumente) L.P. introduces the new N-216 NEXLINE high-load piezo linear motors. These ultra-precision nanopositioning actuators provide travel ranges to 20 mm and push / pull forces to 600 N (130 lb).